These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 30353366)

  • 41. [Effects of neoadjuvant chemoradiotherapy on the rates of sphincter preserving surgery in lower rectal cancer and analysis of their prognostic factors].
    Wang XJ; Chi P; Lin HM; Lu XR; Huang Y; Xu ZB; Huang SH; Sun YW; Ye DX
    Zhonghua Wai Ke Za Zhi; 2016 Jun; 54(6):419-423. PubMed ID: 27938574
    [No Abstract]   [Full Text] [Related]  

  • 42. Long-term results of preoperative chemoradiation for distal rectal cancer correlation between final stage and survival.
    Habr-Gama A; Perez RO; Nadalin W; Nahas SC; Ribeiro U; Silva E Sousa AH; Campos FG; Kiss DR; Gama-Rodrigues J
    J Gastrointest Surg; 2005 Jan; 9(1):90-9; discussion 99-101. PubMed ID: 15623449
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preoperative long course chemoirradiation in a developing country for rectal carcinoma: Kuala Lumpur hospital experience.
    Lee WC; Yusof MM; Lau FN; Phua VC
    Asian Pac J Cancer Prev; 2013; 14(6):3941-4. PubMed ID: 23886211
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Systemic inflammatory response is a predictor of outcome in patients undergoing preoperative chemoradiation for locally advanced rectal cancer.
    Carruthers R; Tho LM; Brown J; Kakumanu S; McCartney E; McDonald AC
    Colorectal Dis; 2012 Oct; 14(10):e701-7. PubMed ID: 22731833
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The prognostic impact of preoperative blood monocyte count in pathological T3N0M0 rectal cancer without neoadjuvant chemoradiotherapy.
    Zhang LN; Xiao W; OuYang PY; You K; Zeng ZF; Ding PR; Pan ZZ; Xu RH; Gao YH
    Tumour Biol; 2015 Sep; 36(10):8213-9. PubMed ID: 25994571
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer].
    Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307
    [No Abstract]   [Full Text] [Related]  

  • 47. Pretreatment blood biomarkers predict pathologic responses to neo-CRT in patients with locally advanced rectal cancer.
    Li A; He K; Guo D; Liu C; Wang D; Mu X; Yu J
    Future Oncol; 2019 Oct; 15(28):3233-3242. PubMed ID: 31373223
    [No Abstract]   [Full Text] [Related]  

  • 48. Predictive factors of disease-free survival after complete pathological response to neoadjuvant radiotherapy for rectal adenocarcinoma: retrospective case series.
    Souadka A; Majbar MA; Benkabbou A; Serji B; Souiki T; Bouchentouf SM; Abid M; El Khannousi B; El Harroudi T; El Malki HO; Raiss M; Ifrine L; Mazaz K; Zentar A; Mohsine R; Souadka A; Belkouchi A; Ahallat M; Hrora A;
    BMC Cancer; 2019 Oct; 19(1):1008. PubMed ID: 31660903
    [TBL] [Abstract][Full Text] [Related]  

  • 49. C-Reactive Protein Level Predicts Survival Outcomes in Rectal Cancer Patients Undergoing Total Mesorectal Excision After Preoperative Chemoradiation Therapy.
    Kim WR; Han YD; Min BS
    Ann Surg Oncol; 2018 Dec; 25(13):3898-3905. PubMed ID: 30288654
    [TBL] [Abstract][Full Text] [Related]  

  • 50. T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival.
    Theodoropoulos G; Wise WE; Padmanabhan A; Kerner BA; Taylor CW; Aguilar PS; Khanduja KS
    Dis Colon Rectum; 2002 Jul; 45(7):895-903. PubMed ID: 12130878
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer.
    Suárez J; Vera R; Balén E; Gómez M; Arias F; Lera JM; Herrera J; Zazpe C
    Colorectal Dis; 2008 Jul; 10(6):563-8. PubMed ID: 18070184
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy?
    Kuo LJ; Liu MC; Jian JJ; Horng CF; Cheng TI; Chen CM; Fang WT; Chung YL
    Ann Surg Oncol; 2007 Oct; 14(10):2766-72. PubMed ID: 17551794
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rsf-1 expression in rectal cancer: with special emphasis on the independent prognostic value after neoadjuvant chemoradiation.
    Lin CY; Tian YF; Wu LC; Chen LT; Lin LC; Hsing CH; Lee SW; Sheu MJ; Lee HH; Wang YH; Shiue YL; Wu WR; Huang HY; Hsu HP; Li CF; Chen SH
    J Clin Pathol; 2012 Aug; 65(8):687-92. PubMed ID: 22569540
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk-Adapted Adjuvant Chemotherapy After Concomitant Fluoropyrimidine-Radiotherapy Neoadjuvant Treatment for Patients With Resectable CT3-4 or N+ Rectal Cancer: Five-Year Disease-Free Survival Results of a Single-Center Series.
    Sastre J; Serrano JJ; Fernández C; Ramirez C; Ortega L; García-Paredes B; Corona J; Alfonso R; Córdoba S; Díaz-Rubio E
    Clin Colorectal Cancer; 2016 Jun; 15(2):128-34. PubMed ID: 26385572
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic value of preoperative carcinoembryonic antigen/tumor size in rectal cancer.
    Cai D; Huang ZH; Yu HC; Wang XL; Bai LL; Tang GN; Peng SY; Li YJ; Huang MJ; Cao GW; Wang JP; Luo YX
    World J Gastroenterol; 2019 Sep; 25(33):4945-4958. PubMed ID: 31543685
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preoperative neutrophil-to-lymphocyte ratio is a more valuable prognostic factor than platelet-to-lymphocyte ratio for nonmetastatic rectal cancer.
    Li H; Song J; Cao M; Wang G; Li L; Zhang B; Li Y; Xu W; Zheng J
    Int Immunopharmacol; 2016 Nov; 40():327-331. PubMed ID: 27664571
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predictive factors of tumor response after neoadjuvant chemoradiation for locally advanced rectal cancer.
    Moureau-Zabotto L; Farnault B; de Chaisemartin C; Esterni B; Lelong B; Viret F; Giovannini M; Monges G; Delpero JR; Bories E; Turrini O; Viens P; Salem N
    Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):483-91. PubMed ID: 21093174
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predicting Pathological Complete Regression with Haematological Markers During Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.
    Lee JH; Song C; Kang SB; Lee HS; Lee KW; Kim JS
    Anticancer Res; 2018 Dec; 38(12):6905-6910. PubMed ID: 30504408
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Efficacy analysis of radiotherapy combined with surgery for locally advanced rectal mucinous adenocarcinoma: a retrospective study based on data of Surveillance, Epidemiology, and End results population].
    Zhang Y; Wang X; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Sun Y; Ye D
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):85-93. PubMed ID: 30703799
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nodal Disease in Rectal Cancer Patients With Complete Tumor Response After Neoadjuvant Chemoradiation: Danger Below Calm Waters.
    Baucom RB; Maguire LH; Kavalukas SL; Geiger TM; Ford MM; Muldoon RL; Hopkins MB; Hawkins AT
    Dis Colon Rectum; 2017 Dec; 60(12):1260-1266. PubMed ID: 29112561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.